Apo-acyclovir Tablets: Ndma Impurity (updated With New Product And Lot Numbers)
Apo-Acyclovir Tablets Recall Summary Apo-Acyclovir Tablets are being recalled across Canada because they contain NDMA, an impurity that should not be present in the medication. This is a Class I recall, meaning there is a potential health risk. The recall affects all Apo-Acyclovir Tablet products distributed in Canada.
- Product
- Apo-Acyclovir Tablets
- Reason
- Contamination
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2023-08-14
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/45a2d436-65c6-41de-9ca0-70f84e0fecfb